Advertisement
Advertisement

ALC

ALC logo

Alcon Inc. Ordinary Shares

74.36
USD
Sponsored
+0.84
+1.15%
Aug 14, 14:43 UTC -4
Open

Alcon Inc. Ordinary Shares Profile

About

Alcon Inc. researches, develops, manufactures, distributes, and sells a full suite of eye care products. Alcon operates within two segments, Surgical and Vision Care. The Surgical segment is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery, and includes implantables, consumables, and surgical equipment required for these procedures. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, and a comprehensive portfolio of ocular health products, including products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers.

Info & Links

CEO

David J. Endicott

Headquarters

Rue Louis-d'Affry 6
Fribourg, V8 1701, SWITZERLAND

Industry

Medical Instruments

Sector

Medical

Website

www.alcon.com

Auditor

PricewaterhouseCoopers LLP

Share holders

--

Employees

25,942

Alcon Inc. Ordinary Shares Statistics

Valuation Measures

Market Capitalization2

35.95B

Enterprise Value

39.10B

Enterprise Value/EBITDA(ttm)

15.40

Price to Earnings Ratio(ttm)

22.57

Price to Sales(ttm)

3.35

Price to Book(mrq)

1.64

Price to Cash(ytd)

13.42

Profitability

Gross Margin(ttm)

55.34%

Operating Margin(ttm)

14.74%

Profit Margin(ttm)

7.70%

Return on Equity(ttm)

7.25%

Return on Invested Capital(ttm)

3.11%

Return on Assets(ttm)

5.07%

Income Statement

Revenue(ttm)

10.63B

Revenue Per Share(ttm)

--

Gross Profit(ttm)

5.89B

EBITDA(ttm)3

2.54B

Net Income Available to Common(ttm)

819.00M

Diluted EPS(ttm)

1.31

Share Statistics

Beta (5Y Monthly)

0.87

52-Week Change

-14.01%

S&P 500 52-Week Change

20.29%

S&P 500 Member

No

Stock Optionable

Yes

Total Shares Outstanding1

--

Dividend Yield

0.00%

Float4

487.10M

% Held by Insiders

1.52%

% Held by Institutions

53.86%

Balance Sheet

Total Cash(mrq)

1.66B

Total Cash Per Share(mrq)

--

Total Debt(mrq)

4.73B

Total Debt/Equity(mrq)

21.39%

Current Ratio(mrq)

2.20%

Quick Ratio(mrq)

1.39%

Book Value Per Share(mrq)

--

Cash Flow

Operating Cash Flow Per Share(ytd)

0.85

Free Cash Flow(ytd)

279.00M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement